Dalhousie University
Program Director: Anita Smith, This email address is being protected from spambots. You need JavaScript enabled to view it.
Administrative Staff: Michelle Pineau, This email address is being protected from spambots. You need JavaScript enabled to view it.
Website: https://medicine.dal.ca/departments/department-sites/obstetrics/education/fellowships.html
Length of Program: 2 years
Accepting trainees every 2 years
Application Deadline: application deadline May 30 and decision date June 30 of the year before fellowship start
Documents Required: *see website (Postgrad application form; CV; letter of intent; 3 references; postgrad director letter)

McGill University
Program Director: Dr. Lisa Merovitz, This email address is being protected from spambots. You need JavaScript enabled to view it.
Admistrative Staff: Dolly Rabbath, Lisa Campbell, This email address is being protected from spambots. You need JavaScript enabled to view it.
Length of Program: 2 years
Accepting trainees every year
Application Deadline: May 15 and decision date June 30 of the year before fellowship start
Documents Required: Required documents are listed on the following website - https://www.mcgill.ca/pgme/fellowships/admissions,
CV, personal statement, 3 reference letters. A specialty Certificate if they have completed the program and a letter of standing from the Program Director.
Additional Note: Funding is available for a fellow for the years 2024-2026

McMaster University
Program Director: Dr. Ola Malabarey, 905-521-2100 ext. 76252
Administrative Staff: Heather Shiskoski, This email address is being protected from spambots. You need JavaScript enabled to view it.
Length of Program: 2 years
Accepting trainees every 2 years
Application Deadline: May 30 and decision date June 30 of the year before fellowship start
Documents Required: https://pgme.mcmaster.ca/apply/fellowships-application/

Schulich School of Medicine and Dentistry, Western University
Program Director: Dr. Queena Chou, This email address is being protected from spambots. You need JavaScript enabled to view it., Tel: (519) 646-6343
Administrative Staff: Samantha Kreamer, This email address is being protected from spambots. You need JavaScript enabled to view it. and Nicole Filson: This email address is being protected from spambots. You need JavaScript enabled to view it., Tel: (519) 685-8500 Ext 56362
Website: https://www.schulich.uwo.ca/obsgyn/education/fellowship_programs/urogynaecology.html
Length of program: 2 years
Accepting trainees every year
Application Deadline: May 30 and decision date June 30 of the year before fellowship start
Documents Required: Candidate Letter of Intent/Personal Statement, CV, 3 Letters of Reference
Additional Notes: Funding is available although individualized based on situation of the candidate (i.e., self-funded by sponsoring agency or not)

University of Alberta (Edmonton)
Program Director: Dr. Erin Kelly, This email address is being protected from spambots. You need JavaScript enabled to view it.
Administrative Staff: Tracey Curtis, This email address is being protected from spambots. You need JavaScript enabled to view it. 
Website: https://www.ualberta.ca/obstetrics-gynecology/education-programs/fellowship-and-postdoc-opportunities/female-pelvic-medicine-fellowship/index.html
Length of program: 2 years
Accepting trainees every 2 years
Application Deadline: May 30 and decision date June 30 of the year before fellowship start
Documents required for application: Application Process
Additional notes for applicants: Overview and Funding and Financial Support

University of British Columbia
Program Director: Roxana Geoffrion, This email address is being protected from spambots. You need JavaScript enabled to view it.
Administrative Staff: Mamta Rohra, This email address is being protected from spambots. You need JavaScript enabled to view it. 
Website: https://obgyn.ubc.ca/education/advanced-training-programs/fpmrs/
Length of Program: 2 years
Accepting 1 fellow every 2 years, next start for July 1, 2024
Application Deadline: May 30 and decision date June 30 of the year before fellowship start
Documents Required: Letter of intent, CV, 3 reference letters
Additional Notes: One-month electives in urogynecology at UBC are encouraged prior to application

University of Calgary
Program Director: Dr. Erin Brennand
Administrative Staff: Katiane Ummels, This email address is being protected from spambots. You need JavaScript enabled to view it.
Accepting fellows every 1 year, with some flexibility available for start dates between July and December
Application Deadline: May 30 and decision date June 30 of the year before fellowship start
Documents Required: CV, 3 Letters of Reference, Letter of Application explaining interest in Urogyne program

Université de Montréal
Program Director: Dr. Barbara Reichetzer, This email address is being protected from spambots. You need JavaScript enabled to view it. 
Administrative Staff: Sandra Charland, This email address is being protected from spambots. You need JavaScript enabled to view it., 514 890-8000, poste 32593
Website: https://deptobsgyn.umontreal.ca/etudes/stages-de-perfectionnement/urogynecologie-et-chirurgie-de-reconstruction-du-plancher-pelvien/
Length of Program: 2 years
Accepting trainees every 2 years
Application Deadline: May 30 and decision date June 30 of the year before fellowship start
Documents Require: Recommendation Letter, Motivation Letter, Resume

University of Ottawa / The Ottawa Hospital
Program Director: Hisham Khalil, BSc, MD, FRCSC, This email address is being protected from spambots. You need JavaScript enabled to view it.
Administrative Staff: Erica Moore, This email address is being protected from spambots. You need JavaScript enabled to view it.
Length of Program: 2 years
Accepting trainees every year
Application Deadline: May 30 and decision date June 30 of the year before fellowship start
Documents Required: 3 reference letters, letter of intent, CV

University of Toronto Urogynecology fellowship
Mount Sinai Hospital Urogynecology fellowship
Sunnybrook Urogynecology fellowship
Program Directors: Patricia Lee, This email address is being protected from spambots. You need JavaScript enabled to view it.; Danny Lovatsis, This email address is being protected from spambots. You need JavaScript enabled to view it.
Administrative Staff: Maureen, This email address is being protected from spambots. You need JavaScript enabled to view it.
Website: http://urogyne.ca/program-descriptions-application/#uoft
Length of program: 2 years
Accepting trainees: Typically, every year for the Joint Fellowship (variable for the Mt Sinai site only or Sunnybrook site only fellowships)
Application deadline: May 30 and decision date June 30 of the year before fellowship start
Documents required for application LOI, CV, 3 references and application form: https://obgyn.utoronto.ca/application-guidelines-and-document-checklist

University of British Columbia

Research Spotlight

Publication Highlights

Geoffrion, Roxana MD*; Koenig, Nicole A. BA*; Zheng, Meimuzi MSc*; Sinclair, Nicholas BSc*; Brotto, Lori A. PhD*; Lee, Terry PhD†; Larouche, Maryse MD MPH‡ Preoperative Depression and Anxiety Impact on Inpatient Surgery Outcomes, Annals of Surgery: March 2021 - Volume 2 - Issue 1 - p e049 doi: 10.1097/AS9.0000000000000049

Roxana Geoffrion, Obstetrics and Gynecology Associate Professor at the University of British Columbia and team aimed to quantify the association of pre-operative depression and anxiety symptoms on postoperative complications and to explore sex differences and sex-specific coping mechanisms in patients undergoing major surgery. They conducted a prospective cohort study of depression and anxiety symptoms using several validated questionnaires in patients undergoing major surgery and the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. Postoperative data collection included a visual analogue scale for pain, narcotic use, post-op complications, length of stay, and readmissions. Pre-operative depression, anxiety and coping mechanisms were associated with adverse surgical outcomes and postoperative pain, with females significantly more impacted than males. Their work also highlighted the use of validated, brief questionnaires that can be easily used in the clinical setting and the importance of holistic pre-operative medical care and patient education. In addition, sleep and exercise emerged as novel therapeutic targets to optimize outcomes for patients undergoing major surgery. Congratulations to Dr Geoffrion and team on publishing one of the largest prospective cohort investigations of mental health in both sexes with recruitment from various surgical specialties in the Annals of Surgery.

2020-2021 Publication List

Moreira Vasconcelos CT, Silva Gomes ML, Geoffrion R, Saboia DM, de Castro Bezerra K, Vasconcelos Neto JA. Pessary evaluation for genital prolapse treatment: from acceptance to successful fitting. Neurourology and Urodynamics. 2020 Nov;39(8):2344-2352.

Harvey MA, Chih HJ, Geoffrion R, Amir B, Bhide A, Miotla P, Rosier PFWM, Offiah I, Pal M, Alas AN. International Urogynecology Consultation Chapter 1 Committee 5: relationship of pelvic organ prolapse to associated pelvic floor dysfunction symptoms: lower urinary tract, bowel, sexual dysfunction and abdominopelvic pain.Int Urogynecol J. 2021 Oct;32(10):2575-2594. doi: 10.1007/s00192-021-04941-5. Epub 2021 Aug 2.PMID: 34338825.

Larouche M, Belzile E, Geoffrion R. Surgical Management of Symptomatic Apical Pelvic Organ Prolapse: A Systematic Review and Meta-analysis. Obstet Gynecol. 2021 Jun 1;137(6):1061-1073. doi: 10.1097/AOG.0000000000004393.PMID: 33957652.

Zhang BY, Wong JMH, A Koenig N, Lee T, Geoffrion R. Risk factors for urinary retention after urogynecologic surgery: A retrospective cohort study and prediction model. Neurourol Urodyn. 2021 Jun;40(5):1182-1191. doi: 10.1002/nau.24676. Epub 2021 Apr 23.PMID: 33891339.

Gong M, Mann GK, Koenig N, Geoffrion R. Documenting Perineal and Obstetrical Anal Sphincter Injury Care at Childbirth: A Cross-Sectional Study. J Obstet Gynaecol Can. 2021 Oct;43(10):1164-1169. doi: 10.1016/j.jogc.2021.02.120. Epub 2021 Mar 6.PMID: 33684531.

Geoffrion R, Larouche M. Guideline No. 413: Surgical Management of Apical Pelvic Organ Prolapse in Women. J Obstet Gynaecol Can. 2021 Apr;43(4):511-523.e1. doi: 10.1016/j.jogc.2021.02.001. Epub 2021 Feb 3.PMID: 33548503.

Geoffrion R, Larouche M. Directive clinique no 413 : Traitement chirurgical du prolapsus génital apical chez les femmes. J Obstet Gynaecol Can. 2021 Apr;43(4):524-538.e1. doi: 10.1016/j.jogc.2021.02.002. Epub 2021 Feb 3.PMID: 33548502.

Geoffrion R, Yang EC, Koenig NA, Brotto LA, Barr AM, Lee T, Allaire C, Bedaiwy MA, Yong P. Recreational Cannabis Use Before and After Legalization in Women With Pelvic Pain. J.Obstet Gynecol. 2021 Jan 1;137(1):91-99. doi: 10.1097/AOG.0000000000004207.PMID: 33278297.

Stothers L, Locke JA, Abdulaziz M, Lazare D, Kavanagh A, Macnab A. Standing open magnetic resonance imaging improves detection and staging of pelvic organ prolapse. Can Urol Assoc J. 2021 Aug 26. doi: 10.5489/cuaj.7244. Online ahead of print.PMID: 34464248.

Brennand EA, Wu G, Houlihan S, Globerman D, Gagnon LH, Birch C, Hyakutake M, Carlson KV, Al-Shankiti H, Robert M, Lazare D, Kim-Fine S; Calgary Women's Pelvic Health Research Group. Two Intraoperative Techniques for Midurethral Sling Tensioning: A Randomized Controlled Trial. Obstet Gynecol. 2020 Sep;136(3):471-481. doi: 10.1097/AOG.0000000000004027.PMID: 32769657 Free PMC article. Clinical Trial.

Walter JE, Brennand EA, Lemos N, Cundiff GW; Canadian Society of Pelvic Medicine Mesh Complications Writing Group. Corrigendum to 'Canadian Society of Pelvic Medicine Response to the Collège des Médecins du Québec Rapport d'Enquête' [Journal of Obstetrics and Gynaecology Canada 43/3 (2021) 298-299]. J Obstet Gynaecol Can. 2021 May;43(5):650. doi: 10.1016/j.jogc.2021.03.008.PMID: 33992128 No abstract available.

Walter JE, Brennand EA, Lemos N, Cundiff GW; Canadian Society of Pelvic Medicine Mesh Complications Writing Group. Letter: Canadian Society of Pelvic Medicine Response to the Collège des Médecins du Québec Rapport d'Enquête. J Obstet Gynaecol Can. 2021 Mar;43(3):298-299. doi: 10.1016/j.jogc.2020.10.004.PMID: 33640099 No abstract available.

Cundiff GW. Le Collège des médecins du Québec devrait-il déterminer l'utilisation adéquate des bandelettes sous-urétrales au Canada? Une analyse du rapport d'enquête. J Obstet Gynaecol Can. 2021 Mar;43(3):285-287. doi: 10.1016/j.jogc.2021.01.007.PMID: 33640096 No abstract available.

Cundiff GW. Should the Collège des Médecins du Québec Determine How Mid-Urethral Slings Are Used in Canada? A Review of the Rapport d'Enquête. J Obstet Gynaecol Can. 2021 Mar;43(3):283-284. doi: 10.1016/j.jogc.2020.09.014.PMID: 33640095 No abstract available.

Chen I, Mallick R, Allaire C, Bajzak KI, Belland LM, Bougie O, Cassell KA, Choudhry AJ, Cundiff GW, Kroft J, Leyland NA, Maheux-Lacroix S, Rajakumar C, Randle E, Robertson D, Thiel JA, Tulandi T, Yong PJ, Laberge PY; Canadian Women's Investigators for Surgical Excellence in Research (CanWISER) Collaboration.J Technicity in Canada: A Nationwide Whole-Population Analysis of Temporal Trends and Variation in Minimally Invasive Hysterectomies. Minim Invasive Gynecol. 2021 May;28(5):1041-1050. doi: 10.1016/j.jmig.2021.01.010. Epub 2021 Jan 18.PMID: 33476750. 10.1002/ijgo.13441. Epub 2020 Dec 8. PMID: 33112417.

Larouche M, Albert AYK, Lipsky N, Walmsley S, Loutfy M, Smaill F, Trottier S, Bitnun A, Yudin MH, Cundiff GW, Money DM. Urinary symptoms and quality of life in women living with HIV: a cross-sectional study. Int Urogynecol J. 2021 Feb;32(2):353-358. doi: 10.1007/s00192-020-04343-z. Epub 2020 May 22.PMID: 32440885. 

McGill University 

Research Spotlight

Publication Highlight

Covarrubias C, Cammisotto PG, Shamout S, Campeau L. Decrease in the ratio proBDNF/BDNF in the urine of aging female patients with OAB. Metabolites 2023 Jun 3;13(6):723.  PMID: 37367881. DOI: 10.3390/metabo13060723

An indisputable link exists between neurotrophins and growth factors (i.e., nerve growth factor/NGF, its precursor, proNGF), and overactive bladder syndrome (OAB). Thus, the team of Dr Lysanne Campeau, Associate Professor of Surgery at McGill University, first aimed to develop a non-invasive tool for diagnosing OAB syndrome in the urine of aging women. MicroRNAs related to NGF and proNGF metabolism (miR-491-5p and miR-592) that negatively control the translation of the matrix metalloproteinase-9 (MMP-9, the primary enzyme degrading NGF) were detected in void urine. Levels of miR-491-5p, the main miRNA that downregulates MMP-9 synthesis, were significantly decreased in urine from OAB patients. Next, concentrations of brain-derived neurotrophic factor (BDNF) and its precursor (proBDNF) were measured in the urine of a cohort of aging female patients with OAB. The ratio of proBDNF/BDNF was significantly decreased in the OAB group, while the level of MMP-9, the enzyme that cleaves proBDNF into BDNF, was increased in OAB compared to controls. These results suggest that neurotrophins are regulated at the levels of proteolytic enzymes converting pro-form to mature form rather than the translational levels; the ratio proBDNF/BDNF could be useful in the phenotyping of OAB in an aging population, and the difference could originate from enhanced MMP-9 enzymatic activity. Their studies confirm the diagnostic and phenotyping value of the urinary ratio proBDNF over mature BDNF. 

2022-2023 Publication List

Kakkar A, Reuveni-Salzman A, Bentaleb J, Belzile E, Merovitz L, Larouche M. Adverse events associated with pessary use over one year among women attending a pessary care clinic. Int Urogynecol J. 2023. Aug;34(8):1765-1770. PMID: 36715742. IF 1.932 doi: 10.1007/s00192-023-05462-z. 

Raina J, Bastrash M-P, Suarthana E, Larouche M. Perioperative complication rates of colpocleisis performed with or without hysterectomy a large population-based study. Int Urogynecol J. 2023. May;34(5):1111-1118. PMID: 36705729. (IF 1.932).  doi: 10.1007/s00192-023-05457-w

Busque AA, Belzile E, Rodrigues K, Larouche M. Major perioperative complications of benign gynecologic procedures at a university-affiliated hospital. McGill Journal of Medicine 2022, 21(6):1-12.

Nguyen LN, Randhawa H, Nadeau G, Cox A, Hickling D, Campeau L, Li J, Welk B, Carlson K. Canadian Urological Association best practice report: diagnosis and management of nocturia. Canadian Urological Association Journal. 2022 Jul;16(7): E336-349. PMID: 35819914. DOI: 10.5489/cuaj.7970

Cammisotto PG, Mossa AH, Shamout S, Campeau L. Urinary levels of miR-491-5p and miR-592 as potential diagnostic biomarkers in female aging patients with OAB: a pilot study. Metabolites 2022 Aug 31;12(9):820. PMID: 36144224. DOI: 10.3390/metabo12090820

Covarrubias C, Cammisotto PG, Shamout S, Campeau L. Decrease in the ratio proBDNF/BDNF in the urine of aging female patients with OAB. Metabolites 2023 Jun 3;13(6):723.  PMID: 37367881.

DOI: 10.3390/metabo13060723

Bouchard, B., Campeau, L. Quality, Value, and Efficacy of Complementary and Alternative Medicine in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome. Curr Bladder Dysfunct Rep 18, 51–58 (2023).

Université de Montréal 

Research Spotlight

Publication Highlight
Chantale Dumoulin, Mélanie Morin, Coraline Danieli, Licia Cacciari, Marie-Hélène Mayrand, Michel Tousignant, Michal Abrahamowicz, Urinary Incontinence and Ageing Study Group. Group-Based vs Individual Pelvic Floor Muscle Training to Treat Urinary Incontinence in Older Women: A Randomized Clinical Trial. JAMA Intern Med. 2020;180(10):1284-1293. doi:10.1001/jamainternmed.2020.2993

The objective of the study was to assess the efficacy of group-based Pelvic Floor Muscle Training (PFMT) relative to individual PFMT for urinary incontinence in older women, using a single-blind, randomized, noninferiority trial conducted in 2 Canadian research centers. 362 community-dwelling women aged 60 years or older with symptoms of stress or mixed urinary incontinence were enrolled. The primary outcome measure was the percentage reduction in urinary incontinence episodes at 1 year, as reported in a 7-day bladder diary and relative to pre-treatment baseline. Individual PFMT and group-based PFMT had similar effectiveness for all secondary outcomes at 1 year. Adverse events were minor and uncommon suggesting that group-based PFMT is not inferior to the recommended individual PFMT for the treatment of stress and mixed urinary incontinence in older women. Widespread use in clinical practice may help increase continence-care affordability and treatment availability.

2020-2023 Publication List

Mercier J, Morin M, Tang A, Reichetzer B, Lemieux MC, Samir K, Zaki D, Gougeon F, Dumoulin C. Pelvic floor muscle training: mechanisms of action for the improvement of genitourinary syndrome of menopause. Climacteric. 2020 Oct;23(5):468-473. doi: 10.1080/13697137.2020.1724942. Epub 2020 Feb 27.

Dumoulin C, Morin M, Danieli C, Cacciari L, Mayrand MH, Tousignant M, Abrahamowicz M, Urinary Incontinence and Aging Study Group. Group-Based vs Individual Pelvic Floor Muscle Training to Treat Urinary Incontinence in Older Women: A Randomized Clinical Trial. JAMA Intern Med. 2020 Oct 1;180(10):1284-1293. doi: 10.1001/jamainternmed.2020.2993.

El-Sayegh B, Dumoulin C, Ali M, Assaf H, Sawan M. A Dynamometer-based Wireless Pelvic Floor Muscle Force Monitoring. Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:6127-6130. doi: 10.1109/EMBC44109.2020.9176660.

Le Berre M, Presse N, Morin M, Larouche M, Campeau L, Hu YX, Reid I, Dumoulin C. What do we really know about the role of caffeine on urinary tract symptoms? A scoping review on caffeine consumption and lower urinary tract symptoms in adults. Neurourol Urodyn. 2020 Jun;39(5):1217-1233. doi: 10.1002/nau.24344. Epub 2020 Apr 9.

Cacciari LP, Kruger J, Goodman J, Budgett D, Dumoulin C. Reliability and validity of intravaginal pressure measurements with a new intravaginal pressure device: The FemFit®. Neurourol Urodyn. 2020 Jan; 39(1):253-260. doi: 10.1002/nau.24179. Epub 2019 Oct 6.

Morin M, Dumoulin C, Bergeron S, Mayrand MH, Khalifé S, Waddell G, Dubois MF; PVD Study Group. Multimodal physical therapy versus topical lidocaine for provoked vestibulodynia: a multicenter, randomized trial. Am J Obstet Gynecol. 2021 Feb;224(2):189.e1-189.e12.

doi: 10.1016/j.ajog.2020.08.038. Epub 2020 Aug 18.

Fehlmann A, Reichetzer B, Ouellet S, Tremblay C, Clermont ME. Establishing a peripartum perineal trauma clinic: a narrative review.Int Urogynecol J. 2021 Jul;32(7):1653-1662. doi: 10.1007/s00192-020-04631-8. Epub 2021 Jan 5.

Pedofsky L, Nielsen PMF, Budgett D, Nemec K, Dumoulin C, Kruger J. Using codesign to develop a mobile application for pelvic floor muscle training with an intravaginal device (femfit®). Neurourol Urodyn. 2021 Nov;40(8):1900-1907. doi: 10.1002/nau.24775. Epub 2021 Aug 31.

Dumoulin C, Cacciari L, Mayrand MH. Implementing Group-Based Pelvic Floor Muscle Training in Clinical Practice-Reply. JAMA Intern Med. 2021 Mar 1;181(3):406-407. doi: 10.1001/jamainternmed.2020.7110.

Cacciari LP, Morin M, Mayrand MH, Tousignant M, Abrahamowicz M, Dumoulin C. Pelvic floor morphometrical and functional changes immediately after pelvic floor muscle training and at 1-year follow-up, in older incontinent women. Neurourol Urodyn. 2021 Jan;40(1):245-255. doi: 10.1002/nau.24542. Epub 2020 Oct 19.

Harvey MA, Lemieux MC, Robert M, Schulz JA. Guideline No. 411: Vaginal Pessary Use.J Obstet Gynaecol Can. 2021 Feb;43(2):255-266.e1. doi: 10.1016/j.jogc.2020.11.013. Epub 2020 Nov 26.

Bø K, Anglès-Acedo S, Batra A, Brækken IH, Chan YL, Jorge CH, Kruger J, Yadav M, Dumoulin C. International Urogynecology Consultation Chapter 3 Committee 2: Conservative treatment of patient with pelvic organ prolapse: Pelvic floor muscle training. Int Urogynecol J. 2022 Oct;33(10):2633-2667. doi: 10.1007/s00192-022-05324-0. Epub 2022 Aug 18.

Cacciari LP, Morin M, Mayrand MH, Dumoulin C. Never Too Late to Train: The Effects of Pelvic Floor Muscle Training on the Shape of the Levator Hiatus in Incontinent Older Women. Int J Environ Res Public Health. 2022 Sep 4;19(17):11078. doi: 10.3390/ijerph191711078.

Parker-Autry C, Neiberg R, Leng XI, Matthews CA, Dumoulin C, Kuchel G, Kritchevsky SB. Examining the Role of Nonsurgical Therapy in the Treatment of Geriatric Urinary Incontinence. Obstet Gynecol. 2022 Aug 1;140(2):243-251. doi: 10.1097/AOG.0000000000004852. Epub 2022 Jul 6.

Cacciari LP, Kouakou CR, Poder TG, Vale L, Morin M, Mayrand MH, Tousignant M, Dumoulin C. Group-based pelvic floor muscle training is a more cost-effective approach to treat urinary incontinence in older women: economic analysis of a randomised trial. J Physiother. 2022 Jul;68(3):191-196. doi: 10.1016/j.jphys.2022.06.001. Epub 2022 Jun 23.

El-Sayegh B, Dumoulin C, Ali M, Assaf H, De Jong J, Sawan M, Leduc-Primeau F. Portable Dynamometer-Based Measurement of Pelvic Floor Muscle Force. IEEE J Transl Eng Health Med. 2022 Nov 18;11:44-53. doi: 10.1109/JTEHM.2022.3223258. eCollection 2023.

Le Berre M, Filiatrault J, Reichetzer B, Dumoulin C. Feasibility, acceptability and effects of a group pelvic floor muscle telerehabilitation program to treat urinary incontinence in older women. Digit Health. 2022 Oct 26;8:20552076221123720. doi: 10.1177/20552076221123720. eCollection 2022 Jan-Dec.

Robinson D, Prodigalidad LT, Chan S, Serati M, Lozo S, Lowder J, Ghetti C, Hullfish K, Hagen S, Dumoulin C. International Urogynaecology Consultation chapter 1 committee 4: patients' perception of disease burden of pelvic organ prolapse. Int Urogynecol J. 2022 Feb;33(2):189-210. doi: 10.1007/s00192-021-04997-3. Epub 2022 Jan 3.

Le Berre M, Filiatrault J, Reichetzer B, Dumoulin C. Group-Based Pelvic Floor Telerehabilitation to Treat Urinary Incontinence in Older Women: A Feasibility Study. Int J Environ Res Public Health. 2023 May 11;20(10):5791. doi: 10.3390/ijerph20105791.

Mercier J, Dumoulin C, Carrier-Noreau G. Pelvic floor muscle rehabilitation for genitourinary syndrome of menopause: why, how and when? Climacteric. 2023 Aug;26(4):302-308.

doi: 10.1080/13697137.2023.2194527. Epub 2023 Apr 5.

Bø K, Anglès-Acedo S, Batra A, Brækken IH, Chan YL, Jorge CH, Kruger J, Yadav M, Dumoulin C. Strenuous physical activity, exercise, and pelvic organ prolapse: a narrative scoping review. Int Urogynecol J. 2023 Jun;34(6):1153-1164. doi: 10.1007/s00192-023-05450-3. Epub 2023 Jan 24.

Cyr MP, Dostie R, Camden C, Dumoulin C, Bessette P, Pina A, Gotlieb WH, Lapointe-Milot K, Mayrand MH, Morin M. Acceptability of multimodal pelvic floor physical therapy to treat dyspareunia after gynecological malignancies: a qualitative study of women's views and experiences. Int Urogynecol J. 2023 May;34(5):1061-1073. doi: 10.1007/s00192-022-05304-4. Epub 2022 Aug 10.

El-Sayegh B, Cacciari LP, Primeau FL, Sawan M, Dumoulin C. The state of pelvic floor muscle dynamometry: A scoping review. Neurourol Urodyn. 2023 Feb;42(2):478-499. doi: 10.1002/nau.25101. Epub 2022 Dec 7.

Sanses TVD, Zillioux J, High RA, Dengler KL, Ackenbom MF, DuBeau CE, Alperin M, Wagg A, Birder LA, Dumoulin C, Bavendam T. Evidence-Informed, Interdisciplinary, Multidimensional Action Plan to Advance Overactive Bladder Research and Treatment Initiatives: Directives From State-of-the-Science Conference on Overactive Bladder and Cognitive Impairment. Urogynecology (Phila). 2023 Jan 1;29(1S Suppl 1):S20-S39. doi: 10.1097/SPV.0000000000001274. Epub 2022 Oct 21.

Dengler KL, High RA, Moga DC, Zillioux J, Wagg A, DuBeau CE, Ackenbom MF, Alperin M, Dumoulin C, Birder LA, Mazloomdoost D, Lai HH, Sung VW, Gray SL, Sanses TVD. Overactive Bladder and Cognitive Impairment: The American Urogynecologic Society and Pelvic Floor Disorders Research Foundation State-of-the-Science Conference Summary Report. Urogynecology (Phila). 2023 Jan 1;29(1S Suppl 1):S1-S19. doi: 10.1097/SPV. 0000000000001272. Epub 2022 Oct 22.

Bø K, Anglès-Acedo S, Batra A, Brækken IH, Chan YL, Jorge CH, Kruger J, Yadav M, Dumoulin C. Are hypopressive and other exercise programs effective for the treatment of pelvic organ prolapse? Int Urogynecol J. 2023 Jan;34(1):43-52. doi: 10.1007/s00192-022-05407-y. Epub 2022 Nov 23.

Marie-Eve Clermont, Audrey Carrier-Leclerc. Les prolapsus du plancher pelvien, une question de qualité de vie. Le Médecin du Québec, vol. 58, no. 5, May 2023.